丙泊酚用于慢诱导纤维支气管镜引导经鼻气管内插管术的适宜效应室浓度探讨

Appropriate effect-site concentration of propofol for sedation during fiberoptic nasotracheal intubation

  • 摘要: 目的 探索复合芬太尼麻醉时靶控输注(target-controlled infusion,TCI)丙泊酚用于慢诱导纤维支气管镜(fiber-optic bronchoscopy,FOB)引导经鼻气管内插管术的适宜效应室浓度(concentration,Ce)。 方法 我院2015年3 - 7月收治的拟在全麻下行颌面部肿瘤切除术患者112例,男性55例,女性57例,年龄(43.9±12.7)岁,体质量指数(24.0±4.0) kg/m2,美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级Ⅰ~Ⅱ级,随机分为咪唑安定组(M组,n=52)和丙泊酚组(P组,n=60)。入室后两组均静注芬太尼1.5μg/kg,M组静注咪唑安定0.02 mg/kg,P组TCI丙泊酚。丙泊酚初始血浆靶浓度(plasma concentration,Cp)为1.2μg/ml。根据脑电双频指数(bispectral index,BIS)追加咪唑安定或调整丙泊酚Cp。BIS值降至85时环甲膜穿刺注射2%丁卡因2.5 ml,1%丁卡因2 ml行鼻腔黏膜表面麻醉。BIS值降至70~80时放置FOB。FOB进入声门后,两组均静注丙泊酚1 mg/kg,放置气管导管并确定其位置,完成麻醉诱导。记录术中及术后情况,记录环甲膜穿刺和放置FOB时丙泊酚Ce。 结果 两组气管内插管难易评分、不良记忆评分、呛咳或误吸发生率以及气管插管时间差异均无统计学意义。与M组比较,P组气道阻塞评分降低(P< 0.05),舒适度增加(P< 0.05),术后咽痛评分降低(P< 0.05)。环甲膜穿刺和放置FOB时丙泊酚Ce分别为(0.7±0.2)μg/ml和(1.1±0.3)μg/ml。 结论 复合芬太尼1.5 μg/kg环甲膜穿刺时丙泊酚Ce为(0.7±0.2)μg/ml,放置FOB时丙泊酚Ce为(1.1±0.3)μg/ml,辅助表面麻醉用于慢诱导经鼻气管内插管安全可行,且优于静脉滴注咪唑安定,但放置气管导管时需静注丙泊酚1 mg/kg。

     

    Abstract: Objective To explore the appropriate effect-site concentration (Ce) of propofol target-controlled infusion (TCI) combined with fentanyl for sedation during fiber-optic bronchoscopy (FOB)-assisted nasotracheal intubation. Methods One hundred and twelve patients undergoing general anesthesia with American Society of Anesthesiologists (ASA) gradeⅠ-Ⅱ for oral cancer surgery admitted to Chinese PLA General Hospital from March 2015 to July 2015 were enrolled in this study. There were 55 males and 57 females with average age of (43.9±12.7) years and body mass index of (24.0±4.0) kg/m2, and they were randomly assigned into midazolam group (group M, n=52) and propofol group (group P, n=60). All patients received fentanyl (1.5 µg/kg) after entering the operating room. Patients in group M were injected with midazolam (0.02 mg/kg), and patients in group P were infused propofol TCI at an initial plasma concentration (Cp) of 1.2 µg/ml. Doses of midazolam and Ces of propofol were adjusted according to bispectral index (BIS). 2.5 ml of 2% tetracaine was injected into tracheal through cricothyroid membrane, naso-pharyngeal membrane was infiltrated with 2 ml of 1% tetracaine for topical anesthesia in both groups until BIS value fell to 85. FOB was loaded when BIS value was between 70 and 80. Tracheal tube was placed once FOB passed the glottis, patients in both groups were administrated propofol (1 mg/kg) at the same time. General anesthesia was commenced after nasotracheal tube was secured. Intraoperative and postoperative events were recorded. Propofol Ces at the time of cricothyroid membrane puncture and FOB placed were recorded, respectively. Results There were no significant differences between two groups in the degree of difficult intubation, pain memory, incidence of cough or aspiration and tracheal intubation time. Compared with group M, airway obstruction score and postoperative sore throat score decreased significantly in group P (P<0.05), while comfort degree of patients increased significantly in group P (P<0.05). The mean Ces of propofol at the time of cricothyroid membrane puncture and FOB placed was (0.7±0.2) µg/ml and (1.1±0.3) µg/ml, respectively. Conclusion Combined with fentanyl (1.5 µg/kg), the propofol mean Ce (0.7±0.2) µg/ml required for cricothyroid membrane puncture and mean Ce (1.1±0.3) µg/ml required for fibreoptic endoscopy are safe and feasible when it is used for supplement of topical anesthesia for FOB-assisted nasotracheal intubation, and it is superior to midazolam, but additional propofol (1 mg/kg) needs to be injected when nasotracheal tube is placed.

     

/

返回文章
返回